Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neutrophil Elastase and Elafin as Prognostic Biomarker for Acute Respiratory Distress Syndrome

NCT02944279 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT02944279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02944279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neutrophil Elastase and Elafin as Prognostic Biomarker for Acute Respiratory Distress Syndrome
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
August 31, 2014
Enrollment
500 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, ards